Patents
Patents for C07K 19 - Hybrid peptides (29,428)
10/2008
10/09/2008US20080248057 Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation
10/09/2008US20080248031 Cell surface molecule mediating cell adhesion and signal transmission
10/09/2008CA2682227A1 Insecticidal proteins
10/09/2008CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants
10/08/2008EP1978036A1 A mycobacterium tuberculosis fusion protein and uses thereof
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1976992A1 Methods and compositions for the detection and isolation of ligands
10/08/2008EP1976876A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
10/08/2008EP1863850A4 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same
10/08/2008EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer
10/08/2008EP1071779B1 Vertebrate patched-2 protein
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101280022A Fused protein of D-aminoacid oxidase, carrier and application thereof
10/08/2008CN101280021A Engineered protein against shrimp white spot syndrome virus, preparation and use thereof
10/08/2008CN101280020A Fused protein of human serum albumin and human insulin C-peptide, and preparation thereof
10/08/2008CN101280019A Fused protein of human serum albumin and human granulocyte colony stimulating factor mutant, and preparation thereof
10/08/2008CN101280018A Fused protein of mutant human interleukin-2 and human serum albumin, and preparation thereof
10/08/2008CN101280017A Fused protein of human brain natriuretic peptide diad [(BNP)2] and human serum albumin (HAS), and preparation thereof
10/08/2008CN100424096C Survivin mutant containing HIV transduction structural area and its preparation method and uses
10/08/2008CN100424095C Recombinant targeted toxin against HIV-1
10/07/2008US7432356 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
10/07/2008US7432348 Novel Protein Histidine Phosphatase Interacting Partner of 180 KD; polypeptides/polynucleotides in diagnostic assays;genetic engineering; identifying agonists and antagonists; conditions having PHPIP-180 imbalance; cardiovascular diseases; nervous system disorders; antitumor, - carcinogenic agents
10/07/2008US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7432053 Fluorescent protein from Aequorea coerulscens and methods for using the same
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008CA2237296C Process for the preparation of peptides by way of streptavidin fusion proteins
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/07/2008CA2209426C Human pak65
10/07/2008CA2149319C Haemophilus outer membrane protein
10/07/2008CA2087494C Soluble ldl receptor, its production and use
10/02/2008WO2008118849A2 Hiv-1 protease inhibitors
10/02/2008WO2008118093A1 Fusion protein capable of degrading amyloid beta peptide
10/02/2008WO2008117792A1 Fluorescent labeled fused protein for assaying adenosine triphosphate
10/02/2008WO2008116648A2 Novel glp-1 fusion peptides, their production and use
10/02/2008WO2008116299A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008WO2008116262A1 Methods and compositions for treating prostate cancer
10/02/2008WO2007016591A3 Compositions and methods for monitoring and altering protein folding and solubility
10/02/2008US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders
10/02/2008US20080242839 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
10/02/2008US20080242624 Cyclin D Polynucleotides, Polypeptides and Uses Thereof
10/02/2008US20080242590 New Method 706
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241116 Using vector comprising nucleotide sequences coding serine phage intergrase to transfer heterologous nucleotide sequences into cells; inproving exogenous gene expression; gene therapy
10/02/2008CA2717659A1 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008CA2681917A1 Methods and compositions for treating prostate cancer
10/02/2008CA2681718A1 Hiv-1 protease inhibitors
10/02/2008CA2681404A1 Fusion protein capable of degrading amyloid beta peptide
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008CA2680837A1 Mek ligands and polynucleotides encoding mek ligands
10/02/2008CA2653967A1 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/01/2008EP1975620A2 Three hybrid assay system
10/01/2008EP1975176A1 Novel glp-1 fusion peptides, their production and use
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974750A1 Preventive or therapeutic agent and method for immune disease
10/01/2008EP1974749A1 Cripto blocking antibodies and uses thereof
10/01/2008EP1974034A1 Polypeptide targeting to mitochondria
10/01/2008EP1973953A2 Compositions and methods for treating obesity and related metabolic disorders
10/01/2008EP1866340A4 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same
10/01/2008CN101275147A Expression vector and fused protein of human differential initiator 3 and preparation thereof
10/01/2008CN101274960A Genes associated with leishmania parasite virulence
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
10/01/2008CN100422210C Recombinant protective protein from streptococcus pneumoniae
10/01/2008CN100422209C Sea snail toxin variant polypeptide compound, its preparation process and application thereof
10/01/2008CN100421730C Immunogenic composition
10/01/2008CA2654894A1 Csf3r polypeptides and uses thereof
09/2008
09/30/2008US7430476 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
09/30/2008US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease
09/30/2008US7429645 Humanized anti-lymphotoxin beta receptor antibodies
09/30/2008US7429644 Comprises lymphotoxin beta receptor (LT-BETA-R) immunoglobulin for treatment of tumor disorders
09/30/2008US7429643 POSH nucleic acids, polypeptides and related methods
09/30/2008US7429384 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis
09/30/2008US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/25/2008WO2008114733A1 Anti-claudin-4 antibody
09/25/2008WO2008113601A1 Glp-1 fusion peptides conjugated to polymer(s), their production and use
09/25/2008WO2008077397A3 Method and means for concentrating, removing, and detecting gram-positive bacteria
09/25/2008US20080234469 Binding to monoclonal antibodies; antitumor agents
09/25/2008US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
09/25/2008US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue
09/25/2008US20080233629 Fusion protein for use in genration of preferential biopolymers in plants
09/25/2008US20080233609 Spirolactam Targeting Compounds and Related Compounds
09/25/2008US20080233596 Chimeric human t1r1 taste receptor polypeptides and compositions containing same
09/25/2008US20080233110 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
09/25/2008CA2680708A1 Metal-binding therapeutic peptides
09/24/2008EP1972689A2 A mutated immunoglobulin-binding protein
09/24/2008EP1972349A1 GLP-1 fusion peptides conjugated to polymer(s), their production and use
09/24/2008EP1971684A1 Chimaeric fusion protein with superior chaperone and folding activities
09/24/2008EP1368476B1 Rearranged squamous cell carcinoma antigen genes ii
09/24/2008EP1029046B1 Wnt-1 inducible genes
09/24/2008CN101273134A Glp/1/exendin 4 igg fc fusion constructs for treatment of diabetes
09/24/2008CN101273058A GLP-1 ( glucagon-like peptide-1 ) fusion polypeptides with increased peptidase resistance
09/24/2008CN101270163A Single-chain fragment antibody-polypeptide amalgamation protein and uses thereof
09/23/2008US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
09/23/2008US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits
09/23/2008CA2294598C Transcriptional activators with graded transactivation potential
09/23/2008CA2187283C Circularly permuted ligands and circularly permuted chimeric molecules
09/18/2008WO2008110653A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 295